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Sir,
A recent study by Bannwarth and colleagues has shown that
variation in the CHCHD10 gene is a cause of familial amyotrophic
lateral sclerosis (ALS) and frontotemporal dementia (FTD)
(Bannwarth et al., 2014). The study identified a c.176C4T
(p.Ser59Leu, NM_213720.1) missense mutation in a multi-
generational kindred. In the present study, we performed
genome sequencing of four affected individuals from a large
ALS family (USALS#5). This identified a G to T transversion at
position c.44 (chr22:24,109,778, hg19) that segregated with dis-
ease within this pedigree and leads to a p.R15L amino acid change
in exon two of the CHCHD10 mitochondrial protein. Previous at-
tempts to identify the causative mutation in this family using an
exome sequencing approach failed to identify this variant due to
poor sequence coverage in this genomic region. The variant was
not described as a human polymorphism in the Single Nucleotide
Polymorphism (SNP) database (http://www.ncbi.nlm.nih.gov/
SNP/, build 141) and was not found in 1158 control individuals
of the Exome Sequencing Project (http://snp.gs.washington.edu/
SeattleSeqAnnotation138/).
To further assess the mutation burden in patients, we Sanger
sequenced all exons of CHCHD10 in an additional series of 84
patients diagnosed with familial ALS according to the El Escorial
criteria (Brooks, 1994). These samples did not carry the C9orf72
hexanucleotide repeat expansion or known mutations in ALS
genes including SOD1, TARDBP, FUS, VCP, PFN1, UBQLN1,
MATR3, SQSTM1, OPTN, and HNPNPA2B1 (Renton et al.,
2014). The ethical review boards at each institution approved
the study, and all participants provided informed consent.
Our mutational screening of CHCHD10 identified the same
p.R15L mutation discovered in the USALS#5 family in two addi-
tional familial ALS cases (www.coriell.org, ND10928 and
ND11809). Analysis of genome-wide SNP chip data indicates
that all six patients carrying the p.R15L variant share a 6.2 Mb
haplotype across the gene.
Our data demonstrate that mutations in CHCHD10 are a rela-
tively common cause of familial ALS and that pathogenic variants
are concentrated in exon 2. This represents the first time, to our
knowledge, that genome sequencing has been applied to familial
ALS. The primary advantage of this methodology is improved
coverage of protein-coding regions of the genome, particularly
in GC-rich regions that may not be effectively captured by the
oligonucleotide baits that are central to exome sequencing. It is
also noteworthy that patients in the pedigree reported by
Bannwarth and colleagues had reliable evidence of mitochondrial
myopathy. Two other ALS genes, VCP and MATR3, have been
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associated with clinical myopathy (Johnson et al., 2010, 2014),
suggesting that muscle involvement may be more common in fa-
milial ALS than previously appreciated.
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